Drug · DIN 02406160
SILDENAFIL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 25, 2024; first marketed June 21, 2013.
- Drug Identification Number (DIN)
- 02406160
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sildenafil G04BE03
- Class
- Human
- Record last updated
- March 31, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SILDENAFIL (SILDENAFIL CITRATE) | 100 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 28, 2023: NOC 31504Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
- May 10, 2013: NOC 14359Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named SILDENAFIL
- DIN 02317559 · Marketed
- DIN 02317575 · Marketed
- DIN 02317583 · Marketed
- DIN 02400693 · Marketed
- DIN 02400707 · Marketed
- DIN 02400715 · Marketed
- DIN 02406152 · Marketed
- DIN 02424312 · Marketed
- DIN 02424320 · Marketed
- DIN 02537737 · Marketed
- DIN 02540770 · Marketed
- DIN 02424304 · Approved
- DIN 02433303 · Cancelled Pre Market
- DIN 02433311 · Cancelled Pre Market
- DIN 02433338 · Cancelled Pre Market
- DIN 02434679 · Approved
- DIN 02434687 · Approved
- DIN 02434695 · Approved
- DIN 02450925 · Approved
- DIN 02450933 · Approved